A Rare Presentation of Fahr's Syndrome Associated With Secondary Hyperparathyroidism

Overview

Journal Clin Case Rep

Date 2025 Jan 21

PMID 39835167

Authors

Simin Najafgholian

Mahbod Soltani

Sanaz Amirian

Negar Pourahmadian

Affiliations

Soon will be listed here.

Abstract

Fahr's syndrome (FS) is a rare disorder characterized by intracerebral calcification, presenting with various neuropsychiatric symptoms. This case highlights a rare presentation of FS with secondary hyperparathyroidism. It underscores the importance of comprehensive evaluation of early symptoms, effective use of diagnostic procedures, and proper management of symptoms.

References

Komaba H, Kakuta T, Fukagawa M . Management of secondary hyperparathyroidism: how and why?. Clin Exp Nephrol. 2017; 21(Suppl 1):37-45. DOI: 10.1007/s10157-016-1369-2. View

Block G, Bushinsky D, Cunningham J, Drueke T, Ketteler M, Kewalramani R . Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials. JAMA. 2017; 317(2):146-155. DOI: 10.1001/jama.2016.19456. View

Yasir Shah S, Hadi F, Idrees M, Levin-Carrion Y, Pande H, Oorloff M . Fahr's Syndrome Secondary to Primary Hypoparathyroidism Presenting With Seizures and the Role of Steroid Therapy. Clin Med Insights Case Rep. 2023; 16:11795476231178119. PMC: 10240851. DOI: 10.1177/11795476231178119. View

Haugarvoll K, Johansson S, Tzoulis C, Haukanes B, Bredrup C, Neckelmann G . MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis. 2013; 8:1. PMC: 3567975. DOI: 10.1186/1750-1172-8-1. View

Li W, Hsieh Y, Chen P, Lee C, Tsai T . Idiopathic young-onset Fahr's disease with schizophrenia-like presentation: a case report. Front Psychiatry. 2024; 15:1391607. PMC: 11148442. DOI: 10.3389/fpsyt.2024.1391607. View

Nijjer S, Ghosh A, Dubrey S . Hypocalcaemia, long QT interval and atrial arrhythmias. BMJ Case Rep. 2012; 2010:bcr0820092216. PMC: 3029862. DOI: 10.1136/bcr.08.2009.2216. View

Kelly A, Levine M . Hypocalcemia in the critically ill patient. J Intensive Care Med. 2011; 28(3):166-77. DOI: 10.1177/0885066611411543. View

Donzuso G, Mostile G, Nicoletti A, Zappia M . Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features. Neurol Sci. 2019; 40(11):2251-2263. PMC: 6817747. DOI: 10.1007/s10072-019-03998-x. View

Katwal S, Bhandari S, Ghimire A, Ghimire P . Fahr's syndrome with hypoparathyroidism, thrombocytopenia, and seizure: a rare case report. Ann Med Surg (Lond). 2023; 85(8):4131-4133. PMC: 10406094. DOI: 10.1097/MS9.0000000000001032. View

Saleem S, Aslam H, Anwar M, Anwar S, Saleem M, Saleem A . Fahr's syndrome: literature review of current evidence. Orphanet J Rare Dis. 2013; 8:156. PMC: 3853434. DOI: 10.1186/1750-1172-8-156. View

10.

Kalampokini S, Georgouli D, Dadouli K, Ntellas P, Ralli S, Valotassiou V . Fahr's syndrome due to hypoparathyroidism revisited: A case of parkinsonism and a review of all published cases. Clin Neurol Neurosurg. 2021; 202:106514. DOI: 10.1016/j.clineuro.2021.106514. View

11.

Jaworski K, Styczynska M, Mandecka M, Walecki J, Kosior D . Fahr Syndrome - an Important Piece of a Puzzle in the Differential Diagnosis of Many Diseases. Pol J Radiol. 2018; 82:490-493. PMC: 5894054. DOI: 10.12659/PJR.902024. View

12.

Cunningham J, Locatelli F, Rodriguez M . Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011; 6(4):913-21. DOI: 10.2215/CJN.06040710. View

13.

Lemos R, Ferreira J, Keasey M, Oliveira J . An update on primary familial brain calcification. Int Rev Neurobiol. 2013; 110:349-71. DOI: 10.1016/B978-0-12-410502-7.00015-6. View

14.

Debbabi W, Khelifi D, Kharrat I, Samet S . Fahr syndrome discovered in adulthood revealing a rare mutation in pseudohypoparathyroidism type 1a in a Tunisian family. Clin Case Rep. 2022; 10(5):e05849. PMC: 9109644. DOI: 10.1002/ccr3.5849. View

15.

Snijders B, Mathijssen G, Peters M, Emmelot-Vonk M, de Jong P, Bakker S . The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial. Orphanet J Rare Dis. 2024; 19(1):49. PMC: 10851566. DOI: 10.1186/s13023-024-03039-7. View

16.

Perugula M, Lippmann S . Fahr's Disease or Fahr's Syndrome?. Innov Clin Neurosci. 2016; 13(7-8):45-6. PMC: 5022990. View

17.

Di Iorio B, Bellasi A, Russo D . Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol. 2012; 7(3):487-93. DOI: 10.2215/CJN.03820411. View

18.

Asokan A, DSouza S, Jeganathan J, Pai S . Fahr's Syndrome- An Interesting Case Presentation. J Clin Diagn Res. 2013; 7(3):532-3. PMC: 3616573. DOI: 10.7860/JCDR/2013/4946.2814. View

19.

Lauterbach E, Spears T, Prewett M, Price S, Jackson J, Kirsh A . Neuropsychiatric disorders, myoclonus, and dystonia in calcification of basal ganglia pathways. Biol Psychiatry. 1994; 35(5):345-51. DOI: 10.1016/0006-3223(94)90038-8. View